Skip to main content
Top
Published in: Clinical Rheumatology 4/2021

01-04-2021 | Aneurysm | Original Article

Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range

Authors: Qu-ming Zhao, Min Huang, Mei-rong Huang, Sun Chen, Fang Liu, Guo-ying Huang, on behalf of the Shanghai Kawasaki Disease Research Group

Published in: Clinical Rheumatology | Issue 4/2021

Login to get access

Abstract

Objective

To explore the trends in diagnosis of Kawasaki disease (KD) and determine the characteristics for patients outside the usual age range of 6 months to 4 years.

Method

A retrospective review of patients with KD identified in four epidemiological surveys spanning 20 years (1998–2017) in Shanghai was performed.

Results

A total of 8416 patients were included. All in all, 223 (2.6%) were aged 0 to 2 months, 639 (7.6%) were 3 to 5 months, 6556 (77.9%) were 6 months to 4 years, 915 (10.9%) were 5 to 9 years, and 83 (1.0%) were ≥ 10 years. The use of intravenous immunoglobulin increased in all extreme age groups, and delayed treatment rates decreased in all patients except in those aged 0 to 2 months and ≥ 10 years. The number of patients outside the usual age increased over time, but the proportion of these patients did not change significantly. They had more incomplete KD and coronary artery aneurysms (CAA), while those aged 0 to 2 months and ≥ 10 years had more delayed diagnoses in their respective age groups. The incidence of CAA was similar in younger and older children, but the former group had more cases of incomplete KD and abnormal laboratory parameters, while the latter group had longer duration of fever and was more difficult to diagnose promptly.

Conclusions

The proportion of KD outside the usual age range did not increase over time. Older and younger children have different clinical and laboratory characteristics.
Key Points
The number of patients outside the usual age increased over time, but the proportion of these patients did not increase.
• Patients aged 0 to 2 months and ≥ 10 years had more delayed diagnoses in their respective age groups.
• Younger children had more cases of incomplete KD and abnormal laboratory parameters, while older children had longer duration of fever and were more difficult to diagnose promptly.
Literature
6.
go back to reference Grasa CD, Fernandez-Cooke E, Sanchez-Manubens J, Anton J, Crespo D, Garcia M, Lopez A, Lirola Cruz MJ, de la Diaz-Delgado Pena R, Calvo C, Spanish network for the study of Kawasaki disease K-R (2019) Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study. Ann Rheum Dis 78(2):289–290. https://doi.org/10.1136/annrheumdis-2018-213891CrossRefPubMed Grasa CD, Fernandez-Cooke E, Sanchez-Manubens J, Anton J, Crespo D, Garcia M, Lopez A, Lirola Cruz MJ, de la Diaz-Delgado Pena R, Calvo C, Spanish network for the study of Kawasaki disease K-R (2019) Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study. Ann Rheum Dis 78(2):289–290. https://​doi.​org/​10.​1136/​annrheumdis-2018-213891CrossRefPubMed
10.
go back to reference Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39(5):387–391PubMed Chuang CH, Hsiao MH, Chiu CH, Huang YC, Lin TY (2006) Kawasaki disease in infants three months of age or younger. J Microbiol Immunol Infect 39(5):387–391PubMed
15.
go back to reference Kim SH, Kim KH, Kim DS (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46(7):585–590PubMed Kim SH, Kim KH, Kim DS (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46(7):585–590PubMed
18.
go back to reference Ma XJ, Yu CY, Huang M, Chen SB, Huang MR, Huang GY, Shanghai Kawasaki Research G (2010) Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J 123(19):2629–2634PubMed Ma XJ, Yu CY, Huang M, Chen SB, Huang MR, Huang GY, Shanghai Kawasaki Research G (2010) Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J 123(19):2629–2634PubMed
20.
go back to reference McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiovascular S, Anesthesia, Council on E (2017) Prevention, diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999. https://doi.org/10.1161/CIR.0000000000000484CrossRefPubMed McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiovascular S, Anesthesia, Council on E (2017) Prevention, diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927–e999. https://​doi.​org/​10.​1161/​CIR.​0000000000000484​CrossRefPubMed
Metadata
Title
Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range
Authors
Qu-ming Zhao
Min Huang
Mei-rong Huang
Sun Chen
Fang Liu
Guo-ying Huang
on behalf of the Shanghai Kawasaki Disease Research Group
Publication date
01-04-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05361-4

Other articles of this Issue 4/2021

Clinical Rheumatology 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.